Literature DB >> 28534318

Association Between Inflammatory Skin Disease and Cardiovascular and Cerebrovascular Co-Morbidities in US Adults: Analysis of Nationwide Inpatient Sample Data.

Michael C Kwa1, Jonathan I Silverberg2,3,4,5.   

Abstract

BACKGROUND: Psoriasis, atopic dermatitis or eczema (AD-E), pemphigus, bullous pemphigoid (BP), and hidradenitis are chronic inflammatory skin disorders associated with systemic immune activation, considerable symptom burden, stigma, functional disturbances, and mental health symptoms. All of these might increase cardiovascular risk.
OBJECTIVE: The objective of this study was to determine whether these inflammatory skin diseases are associated with increased cardiovascular/cerebrovascular risk and/or disease.
METHODS: We analyzed data from the 2002-2012 National Inpatient Sample, including a representative 20% sample of all US hospitalizations (n = 72,108,077 adults).
RESULTS: In multivariate logistic regression models with propensity score matching, patients hospitalized with versus without a diagnosis the inflammatory skin diseases examined had higher odds of obesity (odds ratio [95% confidence interval] for pemphigus: 1.16 [1.05-1.29]; BP 1.14 [1.06-1.23]; AD-E: 1.82 [1.79-1.86]; psoriasis: 2.36 [2.32-2.41]; hidradenitis: 2.79 [2.59-3.01]). Inflammatory skin disease was also associated with significantly higher odds of different cardiovascular risk factors, including hypertension (pemphigus: 1.39 [1.31-1.48]; BP 1.96 [1.88-2.05]; AD-E: 1.19 [1.17-1.21]; psoriasis: 1.61 [1.59-1.64]), and diabetes mellitus with complications (pemphigus: 1.34 [1.18-1.52]; BP: 2.06 [1.90-2.24]; AD-E: 1.13 [1.10-1.17]; psoriasis: 1.39 [1.35-1.44]), as well as vascular, cardiovascular, and cerebrovascular disease, including peripheral vascular disease (pemphigus: 1.14 [1.00-1.30]; BP: 1.83 [1.69-1.98]; AD-E: 1.18 [1.14-1.22]; psoriasis: 1.32 [1.28-1.35]), peripheral and visceral atherosclerosis (BP: 1.67 [1.53-1.81]; AD-E: 1.16 [1.12-1.20]; psoriasis: 1.27 [1.24-1.30]), pulmonary circulation disorders (pemphigus: 1.67 [1.39-2.01]; BP: 2.17 [1.92-2.45]; AD-E: 1.39 [1.33-1.45]; psoriasis: 1.37 [1.31-1.43]), congestive heart failure (pemphigus: 1.75 [1.60-1.90]; BP: 2.82 [2.68-2.98]; AD-E: 1.10 [1.07-1.13]; psoriasis: 1.05 [1.02-1.07]), history of transient ischemic attack (pemphigus: 1.36 [1.14-1.62]; BP: 2.03 [1.83-2.26]; AD-E: 1.19 [1.15-1.23]; psoriasis: 1.31 [1.26-1.36]), and cerebrovascular disease. In stratified analyses, multiple inflammatory skin diseases were associated with significantly higher rates of obesity, hypertension, and/or diabetes in patients aged <50 years and females.
CONCLUSIONS: Psoriasis, pemphigus, BP, AD-E, and hidradenitis were all associated with increased cardiovascular and cerebrovascular risk, especially at younger age.

Entities:  

Mesh:

Year:  2017        PMID: 28534318     DOI: 10.1007/s40257-017-0293-x

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  11 in total

1.  Long-term Western diet intake leads to dysregulated bile acid signaling and dermatitis with Th2 and Th17 pathway features in mice.

Authors:  Prasant Kumar Jena; Lili Sheng; Kyle Mcneil; Thinh Q Chau; Sebastian Yu; Maija Kiuru; Maxwell A Fung; Samuel T Hwang; Yu-Jui Yvonne Wan
Journal:  J Dermatol Sci       Date:  2019-06-08       Impact factor: 4.563

2.  Association of autoimmune blistering disease, and specifically, pemphigus vulgaris, with cardiovascular disease and its risk factors: a systematic review and meta-analysis.

Authors:  Alex M Rokni; Marissa Ayasse; Adnan Ahmed; Lauren Guggina; Robert W Kantor; Jonathan I Silverberg
Journal:  Arch Dermatol Res       Date:  2022-03-09       Impact factor: 3.017

3.  Relationship between bullous pemphigoid and metabolic syndrome: a 12-year case-control study conducted in China.

Authors:  Bingjie Zhang; Xinyi Chen; Yangchun Liu; Fangyuan Chen; Nan Yang; Li Li
Journal:  Ther Adv Chronic Dis       Date:  2022-10-15       Impact factor: 4.970

4.  Screening for cardiovascular comorbidity in United States outpatients with psoriasis, hidradenitis, and atopic dermatitis.

Authors:  Partik Singh; Jonathan I Silverberg
Journal:  Arch Dermatol Res       Date:  2020-05-11       Impact factor: 3.017

5.  Cardiovascular comorbidities of pediatric psoriasis among hospitalized children in the United States.

Authors:  Lauren Kwa; Michael C Kwa; Jonathan I Silverberg
Journal:  J Am Acad Dermatol       Date:  2017-09-28       Impact factor: 11.527

Review 6.  Associations between atopic dermatitis and other disorders.

Authors:  Jonathan I Silverberg
Journal:  F1000Res       Date:  2018-03-12

7.  Atopic eczema and major cardiovascular outcomes: A systematic review and meta-analysis of population-based studies.

Authors:  Anna Ascott; Amy Mulick; Ashley M Yu; David Prieto-Merino; Morten Schmidt; Katrina Abuabara; Liam Smeeth; Amanda Roberts; Sinéad M Langan
Journal:  J Allergy Clin Immunol       Date:  2018-12-18       Impact factor: 10.793

Review 8.  Type 2 diabetes and psoriasis: links and risks.

Authors:  Jesper Grønlund Holm; Simon Francis Thomsen
Journal:  Psoriasis (Auckl)       Date:  2019-01-17

Review 9.  Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.

Authors:  Amit Garg; Neeta Malviya; Andrew Strunk; Shari Wright; Afsaneh Alavi; Raed Alhusayen; Ali Alikhan; Steven D Daveluy; Isabelle Delorme; Noah Goldfarb; Wayne Gulliver; Iltefat Hamzavi; Tarannum Jaleel; Alexa B Kimball; Joslyn S Kirby; Mark G Kirchhof; Janice Lester; Hadar Lev-Tov; Michelle A Lowes; Robert Micheletti; Lauren A Orenstein; Vincent Piguet; Christopher Sayed; Jerry Tan; Haley B Naik
Journal:  J Am Acad Dermatol       Date:  2021-01-23       Impact factor: 15.487

Review 10.  Cardiovascular Disease-Associated Skin Conditions.

Authors:  Lia Hojman; Claudio Karsulovic
Journal:  Vasc Health Risk Manag       Date:  2022-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.